Tokyo Tape
Sign in
← Santen Pharmaceutical

Quarterly report · Q2

4536.TEDINET S100S66I
Period2023-04-01 → 2023-09-30
Filed2023-11-09
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥145.8bn2023-04-01 → 2023-09-30Cons.Revenue IFRS
Revenue¥73.4bn2023-07-01 → 2023-09-30dCons.Revenue IFRS
Revenue¥279.0bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥128.9bn2022-04-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥63.4bn2022-07-01 → 2022-09-30dCons.Revenue IFRS
Operating income¥25.1bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Operating income¥12.3bn2023-07-01 → 2023-09-30dCons.Operating profit loss IFRS
Operating income−¥19.0bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income−¥27.4bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Profit before tax¥24.1bn2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Profit before tax¥11.2bn2023-07-01 → 2023-09-30dCons.Profit loss before tax IFRS
Profit before tax−¥5.8bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥19.1bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax−¥28.2bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥19.3bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥8.9bn2023-07-01 → 2023-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥14.9bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥22.0bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥28.7bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥19.3bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Net income¥8.9bn2023-07-01 → 2023-09-30dCons.Profit loss IFRS
Net income−¥22.0bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income−¥28.7bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Total assets¥427.0bnat 2023-09-30Cons.Assets IFRS
Total assets¥421.2bnat 2023-03-31Cons.Assets IFRS
Total assets¥426.6bnat 2022-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥120.5bnat 2023-09-30Cons.Liabilities IFRS
Total liabilities¥127.9bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥306.5bnat 2023-09-30Cons.Equity IFRS
Net assets / equity¥293.3bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥309.4bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥336.8bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥307.2bnat 2023-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥294.0bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥310.1bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥64.7bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥57.9bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥69.1bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥83.0bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥27.7bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥37.1bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥18.3bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥3.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥26.8bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥18.8bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥19.7bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥37.2bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥16.1bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥52.062023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥24.62023-07-01 → 2023-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥-38.62022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-56.052022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-75.562022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥51.922023-04-01 → 2023-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥24.522023-07-01 → 2023-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥-38.62022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-56.052022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-75.562022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio71.9%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio69.8%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio72.7%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 674
ItemContextValueUnit
Issuance of new shares ss IFRSCurrentYTDDuration_ShareCapitalIFRSMember54000000JPY
Issuance of new shares ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember54000000JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember-14000000JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_TreasurySharesIFRSMember-11767000000JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember1000000JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration_TreasurySharesIFRSMember807000000JPY
Dividends ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember-6009000000JPY
Share based payment transactions ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember-458000000JPY
Other ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember364000000JPY
Other ss IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-364000000JPY
Total transactions with owners IFRSCurrentYTDDuration_ShareCapitalIFRSMember54000000JPY
Total transactions with owners IFRSCurrentYTDDuration_CapitalSurplusIFRSMember-416000000JPY
Total transactions with owners IFRSCurrentYTDDuration_TreasurySharesIFRSMember-10960000000JPY
Total transactions with owners IFRSCurrentYTDDuration_RetainedEarningsIFRSMember-5646000000JPY
Total transactions with owners IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Total transactions with owners IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-364000000JPY
Total transactions with owners IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Equity IFRSCurrentQuarterInstant_ShareCapitalIFRSMember8756000000JPY
Equity IFRSCurrentQuarterInstant_CapitalSurplusIFRSMember9373000000JPY
Equity IFRSCurrentQuarterInstant_TreasurySharesIFRSMember-11324000000JPY
Equity IFRSCurrentQuarterInstant_RetainedEarningsIFRSMember251706000000JPY
Equity IFRSCurrentQuarterInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Equity IFRSCurrentQuarterInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember8798000000JPY
Equity IFRSCurrentQuarterInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember37109000000JPY
Equity IFRSPrior1YearInstant_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Equity IFRSPrior1YearInstant_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember1562000000JPY
Equity IFRSPrior1YearInstant_ShareAcquisitionRightsIFRSMember331000000JPY
Equity IFRSPrior1YearInstant_OtherComponentsOfEquityIFRSMember37781000000JPY
Equity IFRSPrior1YearInstant_EquityAttributableToOwnersOfParentIFRSMember293979000000JPY
Equity IFRSPrior1YearInstant_NonControllingInterestsIFRSMember-683000000JPY
Equity IFRSPrior1YearInstant293297000000JPY
Profit loss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Profit loss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember19280000000JPY
Profit loss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-6000000JPY
Profit loss IFRSCurrentYTDDuration19274000000JPY
Other comprehensive income IFRSCurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember-23000000JPY
Other comprehensive income IFRSCurrentYTDDuration_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember1010000000JPY
Other comprehensive income IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember11370000000JPY
Other comprehensive income IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember11370000000JPY
Other comprehensive income IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-47000000JPY
Other comprehensive income IFRSCurrentYTDDuration11323000000JPY
Comprehensive income IFRSCurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember-23000000JPY
Comprehensive income IFRSCurrentYTDDuration_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember1010000000JPY
Comprehensive income IFRSCurrentYTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Comprehensive income IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember11370000000JPY
Comprehensive income IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember30650000000JPY
Comprehensive income IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-53000000JPY
Comprehensive income IFRSCurrentYTDDuration30597000000JPY
Issuance of new shares ss IFRSCurrentYTDDuration_ShareAcquisitionRightsIFRSMember-108000000JPY
Issuance of new shares ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-108000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2023-07-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass